- Datum09.09.2025
- Uhrzeit17:00 - 18:00 Uhr
- Veranstalter
XTB
J. Klatt
Moderator
Orchestra BioMed Holdings Inc Aktie
Verkaufen
Kaufen
Orchestra BioMed Holdings Inc Chart
Echtzeit-News zu diesem und anderen Unternehmen findest Du hier!
Live-Ticker Orchestra BioMed Holdings Inc Realtime-Kurs
| Handelsplatz | Kurs | +/- (%) | +/- (abs) | Vortag | Zeit | Aktionen |
|---|---|---|---|---|---|---|
| Nasdaq | VK | |||||
| Nasdaq Basic | VK | |||||
| Cboe BZX | VK |
Passende Produkte
| WKN | Long/Short | KO | Hebel | Laufzeit | Bid | Ask |
|---|
Keine Ergebnisse gefunden
Wertentwicklung (Nasdaq)
-1,09 %
Intraday
-0,36 %
1 Woche
0,74 %
1 Monat
-31,75 %
Seit Jahresbeginn
-50,45 %
1 Jahr
-72,34 %
3 Jahre
-75,73 %
5 Jahre
Passender Service zu Orchestra BioMed Holdings Inc
Webinar zu Orchestra BioMed Holdings Inc
Kursinformationen (Nasdaq)
- Tagestief / Hoch ($)-
- 52W-Tief / Hoch ($)2,370-6,500
- Jahrestief / Hoch ($)2,370-6,300
- Schlusskurs (Vortag)
- Eröffnungskurs
- Volumen Intraday
Wichtigste Eigenschaften
Dividenden von Orchestra BioMed Holdings Inc
Keine Dividenden verfügbar
Termine von Orchestra BioMed Holdings Inc
Keine aktuellen Termine
Beschreibung
Orchestra BioMed Holdings, Inc. operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension; and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease. Its products also comprise FreeHold retractors that are minimally invasive surgical device solutions. The company has a strategic collaboration with Medtronic for the development and commercialization of BackBeat CNT for the treatment of hypertension in pacemaker-indicated patients; and a strategic partnership with Terumo Corporation for the development and commercialization of Virtue SAB for the treatment of artery disease. Orchestra BioMed Holdings, Inc. is based in New Hope, Pennsylvania.
